{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:18:34Z","timestamp":1788985114564,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008233","name":"School of Medicine, Shanghai Jiao Tong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272878"],"award-info":[{"award-number":["82272878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.redox.2026.104347","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:35:24Z","timestamp":1786721724000},"page":"104347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["P4HA3-mediated hydroxylation of SLC7A11 drives tyrosine kinase inhibitor resistance by suppressing ferroptosis in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"96","author":[{"given":"Yueming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhuo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-6947","authenticated-orcid":false,"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.redox.2026.104347_bib1","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma: a review","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2026.104347_bib2","unstructured":"\u2018Renal cell carcinoma | Nat. Rev. Dis. Primers\u2019. Accessed: December. 30, 2025. [Online]. Available: https:\/\/www.nature.com\/articles\/nrdp20179."},{"issue":"23","key":"10.1016\/j.redox.2026.104347_bib3","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1111\/bph.16252","article-title":"Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics","volume":"180","author":"Wang","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2026.104347_bib4","article-title":"Sunitinib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers","volume":"67","author":"Jin","year":"2023","journal-title":"Drug Resist. Updat. Rev. Comment. Antimicrob. Anticancer Chemother."},{"issue":"6","key":"10.1016\/j.redox.2026.104347_bib5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.redox.2026.104347_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/cdd.2015.158","article-title":"Ferroptosis: process and function","volume":"23","author":"Xie","year":"2016","journal-title":"Cell Death Differ."},{"issue":"23","key":"10.1016\/j.redox.2026.104347_bib7","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-22-4001","article-title":"DPP9 stabilizes NRF2 to suppress ferroptosis and induce sorafenib resistance in clear cell renal cell carcinoma","volume":"83","author":"Chang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2026.104347_bib8","article-title":"USP20 governs tyrosine kinase inhibitors resistance through ferroptosis evasion by targeting GPX4 in cancers","author":"Wang","year":"2026","journal-title":"Redox Biol."},{"issue":"40","key":"10.1016\/j.redox.2026.104347_bib9","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","article-title":"The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma","volume":"37","author":"Miess","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12943-025-02457-w","article-title":"Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting","volume":"24","author":"Deng","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","article-title":"Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer Commun. Lond. Engl."},{"issue":"8","key":"10.1016\/j.redox.2026.104347_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.redox.2026.104347_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217942","article-title":"OTUD3-mediated stabilization of SLC7A11 drives sunitinib resistance by suppressing ferroptosis in clear cell renal cell carcinoma","volume":"632","author":"Xu","year":"2025","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.redox.2026.104347_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/cdd.2011.165","article-title":"Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression","volume":"19","author":"Lewerenz","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.redox.2026.104347_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101993","article-title":"Activation of the eIF2\u03b1\/ATF4 axis drives triple-negative breast cancer radioresistance by promoting glutathione biosynthesis","volume":"43","author":"Bai","year":"2021","journal-title":"Redox Biol."},{"issue":"7545","key":"10.1016\/j.redox.2026.104347_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.redox.2026.104347_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/10409231003627991","article-title":"Prolyl 4-hydroxylase","volume":"45","author":"Gorres","year":"2010","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.redox.2026.104347_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1042\/EBC20180053","article-title":"Role of prolyl hydroxylation in the molecular interactions of collagens","volume":"63","author":"Rappu","year":"2019","journal-title":"Essays Biochem."},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib19","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/s41467-018-06893-9","article-title":"Collagen prolyl 4-hydroxylase 1 is essential for HIF-1\u03b1 stabilization and TNBC chemoresistance","volume":"9","author":"Xiong","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.redox.2026.104347_bib20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood-2017-07-794875","article-title":"Prolyl 4-hydroxylase 2 promotes B-cell lymphoma progression via hydroxylation of Carabin","volume":"131","author":"Jiang","year":"2018","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.redox.2026.104347_bib21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/s41388-024-03032-1","article-title":"P4HA2 activates mTOR via hydroxylation and targeting P4HA2-mTOR inhibits lung adenocarcinoma cell growth","volume":"43","author":"Jin","year":"2024","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.redox.2026.104347_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.redox.2026.104347_bib23","unstructured":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches - PubMed\u2019. Accessed: December. 30, 2025. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/39048965\/."},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00012.2016","article-title":"Ubiquitination and the regulation of membrane proteins","volume":"97","author":"Foot","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.redox.2026.104347_bib25","unstructured":"NEDD4 E3 ligase: functions and mechanism in human cancer - PubMed\u2019. Accessed: December. 30, 2025. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/32171886\/."},{"issue":"7","key":"10.1016\/j.redox.2026.104347_bib26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41419-019-1750-7","article-title":"IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-\u03b2 signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.redox.2026.104347_bib27","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1038\/s41375-024-02313-8","article-title":"P4HA2 hydroxylates SUFU to regulate the paracrine Hedgehog signaling and promote B-cell lymphoma progression","volume":"38","author":"Li","year":"2024","journal-title":"Leukemia"},{"issue":"45","key":"10.1016\/j.redox.2026.104347_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202403995","article-title":"Deubiquitylase USP52 promotes bladder cancer progression by modulating ferroptosis through stabilizing SLC7A11\/xCT","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","article-title":"TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.redox.2026.104347_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116746","article-title":"P4HA3 depletion induces ferroptosis and inhibits colorectal cancer growth by stabilizing ACSL4 mRNA","volume":"233","author":"Xu","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"290","key":"10.1016\/j.redox.2026.104347_bib31","doi-asserted-by":"crossref","first-page":"290ra92","DOI":"10.1126\/scitranslmed.3010228","article-title":"Drug-induced regeneration in adult mice","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib32","first-page":"186","article-title":"Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma","volume":"40","author":"Sharma","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbcan.2014.11.002","article-title":"Resistance to sunitinib in renal cell carcinoma: from molecular mechanisms to predictive markers and future perspectives","volume":"1855","author":"Joosten","year":"2015","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer"},{"issue":"8","key":"10.1016\/j.redox.2026.104347_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18504","article-title":"Targeting ferroptosis in renal cell carcinoma: potential mechanisms and novel therapeutics","volume":"9","author":"Yang","year":"2023","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.redox.2026.104347_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41419-023-05719-x","article-title":"PDIA4 confers resistance to ferroptosis via induction of ATF4\/SLC7A11 in renal cell carcinoma","volume":"14","author":"Kang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2026.104347_bib36","unstructured":"\u2018Fatty Acid Oxidation Mediated by Malonyl-CoA Decarboxylase Represses Renal Cell Carcinoma Progression - PubMed\u2019. Accessed: December. 30, 2025. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/37729394\/."},{"issue":"4","key":"10.1016\/j.redox.2026.104347_bib37","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.7150\/ijbs.79853","article-title":"AIM2 promotes renal cell carcinoma progression and sunitinib resistance through FOXO3a-ACSL4 axis-regulated ferroptosis","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"10.1016\/j.redox.2026.104347_bib38","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jprot.2010.01.005","article-title":"Exploring the membrane proteome--challenges and analytical strategies","volume":"73","author":"Helbig","year":"2010","journal-title":"J. Proteonomics"},{"issue":"12","key":"10.1016\/j.redox.2026.104347_bib39","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.tips.2025.10.012","article-title":"Mass spectrometry-based strategies for membrane protein pharmacology","volume":"46","author":"Reiter","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"issue":"10","key":"10.1016\/j.redox.2026.104347_bib40","first-page":"3106","article-title":"SLC7A11\/xCT in cancer: biological functions and therapeutic implications","volume":"10","author":"Lin","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.redox.2026.104347_bib41","article-title":"SLC7A11: the Achilles heel of tumor?","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.redox.2026.104347_bib42","article-title":"P4HA3 drives cervical cancer lymphatic metastasis by facilitating ACLY-mediated ferroptosis resistance","author":"Yuan","year":"2025","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"9","key":"10.1016\/j.redox.2026.104347_bib44","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.chembiol.2022.06.004","article-title":"Context-dependent regulation of ferroptosis sensitivity","volume":"29","author":"Magtanong","year":"2022","journal-title":"Cell Chem. Biol."},{"issue":"1","key":"10.1016\/j.redox.2026.104347_bib45","article-title":"Regulation of SLC7A11 as an unconventional checkpoint in tumorigenesis through ferroptosis","volume":"12","author":"Su","year":"2025","journal-title":"Genes Dis."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726003460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726003460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:01:04Z","timestamp":1788984064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726003460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":45,"alternative-id":["S2213231726003460"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104347","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P4HA3-mediated hydroxylation of SLC7A11 drives tyrosine kinase inhibitor resistance by suppressing ferroptosis in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104347","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104347"}}